Ellen G. Chadwick, MD

Co-Medical Director, Pediatric and Maternal HIV Infection

Irene Heinz Given and John LaPorte Given Chair in Pediatrics and Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: AIDS, AIDS/HIV transmission issues, neonatal infections, and medical education

Specialties, Programs & Conditions

Specialties:

Pediatric Infectious Disease Treatment >

Education & Training

Education: University of Virginia School of Medicine, 1979

Postgraduate Training: Fellowship in pediatric infectious diseases, Children's Memorial Hospital, 1982-1985; Residency in pediatrics, Children's Memorial Hospital, 1979-1982

Board Certifications: Pediatric Infectious Diseases, General Pediatrics

Professional Organizations: American Academy of Pediatrics; American Board of Pediatrics; American Pediatric Society; Infectious Diseases Society of America; Pediatric Infectious Diseases Society

Research

Research Interests: HIV; AIDS; antiretroviral therapy; HIV-infected infants

Publications

Most recent publications

Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy Pediatr Infect Dis J28 (3): 215-9
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results AIDS22 (2): 249-55
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis PLoS Med15 (3): e1002514
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection AIDS31 (8): 1129-1136
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali Pediatr Infect Dis J36 (11): e258-e263
Paraspinal Abdominal Mass and Pain in a Toddler Receiving Therapy for Pneumonia J Pediatric Infect Dis Soc5 (2): 233-5
A 15-year-old boy with dyspnea with exertion Pediatr Ann42 (6): 227-9
Assessment of lopinavir pharmacokinetics with respect to developmental changes in infants and the impact on weight band-based dosing Clin Pharmacol Ther91 (2): 243-9
Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy AIDS25 (5): 643-9
Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age AIDS26 (12): 1483-1490

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

1 Results

Anti-HIV drug combination does not increase preterm birth risk, study suggests

See all News & Stories >